Literature DB >> 32201931

Authors' Reply to Hays: "A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance".

David J Mott1, Grace Hampson2, Martin J Llewelyn3, Jorge Mestre-Ferrandiz2,4, Michael M Hopkins5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32201931     DOI： 10.1007/s40258-020-00573-w

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN： 1175-5652            Impact factor:   2.561


× No keyword cloud information.
  6 in total

1.  Comment on: "A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance".

Authors:  J P Hays
Journal:  Appl Health Econ Health Policy       Date:  2020-06       Impact factor: 2.561

2.  Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial.

Authors:  Paul Little; Michael Moore; Jo Kelly; Ian Williamson; Geraldine Leydon; Lisa McDermott; Mark Mullee; Beth Stuart
Journal:  BMJ       Date:  2014-03-06

3.  Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study.

Authors:  Myriam Gharbi; Joseph H Drysdale; Hannah Lishman; Rosalind Goudie; Mariam Molokhia; Alan P Johnson; Alison H Holmes; Paul Aylin
Journal:  BMJ       Date:  2019-02-27

4.  The impact of diagnostic microbiology on de-escalation of antimicrobial therapy in hospitalised adults.

Authors:  William L Hamilton; Sacha-Marie Pires; Samantha Lippett; Vikesh Gudka; Elizabeth L A Cross; Martin J Llewelyn
Journal:  BMC Infect Dis       Date:  2020-02-03       Impact factor: 3.090

5.  Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trial.

Authors:  Ingvild Vik; Marianne Bollestad; Nils Grude; Anders Bærheim; Eivind Damsgaard; Thomas Neumark; Lars Bjerrum; Gloria Cordoba; Inge Christoffer Olsen; Morten Lindbæk
Journal:  PLoS Med       Date:  2018-05-15       Impact factor: 11.069

6.  A Multinational European Study of Patient Preferences for Novel Diagnostics to Manage Antimicrobial Resistance.

Authors:  David J Mott; Grace Hampson; Martin J Llewelyn; Jorge Mestre-Ferrandiz; Michael M Hopkins
Journal:  Appl Health Econ Health Policy       Date:  2020-02       Impact factor: 2.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.